Tag: GLP-1
-
WHO Adds GLP-1s to Essential Medicines List
Introduction to WHO’s Essential Medicines List The World Health Organization (WHO) plays a crucial role in ensuring that essential medications are accessible to communities in need. The Model List of Essential Medicines (EML) is a guide for countries to prioritize medicines that are critical for public health, and the recent update announced on September 9,…
-
WHO Updates Essential Medicines List to Include GLP-1s
Introduction to WHO’s Essential Medicines List The World Health Organization (WHO) is pivotal in promoting global health by outlining essential medicines necessary for a basic healthcare system. The Model List of Essential Medicines (EML) serves as a guide for countries to ensure access to the most effective medications. In September 2025, the WHO unveiled significant…
-
WHO Updates Essential Medicines List Including GLP-1s
Introduction to WHO’s Essential Medicines List The World Health Organization (WHO) is renowned for its ongoing commitment to global health and well-being. One of its key initiatives is the Model List of Essential Medicines (EML), which outlines the necessary medications for addressing the most critical health needs across populations. Recently, the WHO has updated this…
-
GLP-1 Weight-Loss Drugs: Understanding the Risks for Young Women
Introduction GLP-1 weight-loss drugs are gaining traction among individuals seeking effective solutions for obesity and weight management. However, emerging research indicates that these medications may pose significant risks, particularly for young women of reproductive age. A recent study by Flinders University sheds light on these hidden dangers, prompting a closer examination of the implications for…